About Us

About Us

Oncovask Therapeutics is a California-based, scientist-led biotechnology company founded in 2024 to develop innovative and accessible technologies for precision cancer care.

Our multidisciplinary team brings together expertise in cancer biology, pharmaceutical sciences, drug formulation, mechanical and automation engineering, microfluidics, data science, artificial intelligence, and virtual reality. By integrating these disciplines, we are developing new approaches across three complementary areas: overcoming cancer therapy resistance, developing affordable microfluidic diagnostic technologies, and building AI-enabled digital-twin platforms to support personalized treatment decisions.

Our therapeutic research focuses on targeting difficult-to-drug DNA repair mechanisms that contribute to cancer treatment resistance, with an initial emphasis on restoring sensitivity to PARP inhibitors in resistant cancers. In parallel, we are developing microfluidic technologies for cancer detection and treatment monitoring and computational platforms designed to integrate patient and tumor data to support precision oncology.

Oncovask Therapeutics is registered to pursue U.S. federal small-business research funding opportunities, including the SBIR program, as we advance our technologies toward translational and commercial development.

Our goal is to bring together therapeutics, diagnostics, and digital technologies to make personalized cancer care more effective, accessible, and informed by each patient’s disease biology.

OUR GOAL IS CLEAR: TO ACCELERATE CANCER EARLY DETECTION, OVERCOME TREATMENT RESISTANCE, AND HARNESS AI FOR PERSONALIZED TREATMENT DECISIONS.

Mission & Vision

MISSION

To redefine cancer care through cutting-edge innovations in early detection and therapeutic solutions, fostering hope and improving outcomes for individuals battling cancer globally.

VISION

To establish ourselves as a beacon of excellence in biotechnology, leading the charge toward a future where cancer is no longer a life-threatening diagnosis. Guided by integrity and compassion, we aim to pioneer transformative approaches that empower individuals to conquer cancer and live life to its fullest potential.

OUR
EXPERTISE

CANCER EARLY DETECTION

Our expertise lies in pioneering early detection methods for cancer, facilitating timely intervention, and improving patient outcomes.

At Oncovask Therapeutics, we excel in cancer early detection. Leveraging advanced technologies and a profound understanding of cancer biology, we lead the charge in identifying cancer at its earliest stages. Our mission is simple: to provide accurate, timely detection methods that empower proactive intervention, ultimately saving lives and shaping the future of healthcare.

MOLECULAR CELL BIOLOGY

Molecular cell biology investigates how molecules govern cellular functions, shedding light on disease mechanisms and potential therapeutic targets.

At Oncovask Therapeutics, we specialize in molecular cell biology, uncovering disease pathways and therapeutic targets. With state-of-the-art technologies and a seasoned team, we're driving advancements in precision medicine and personalized therapies to revolutionize patient care.

Cancer therapy resistance

We unravel cancer therapy resistance mechanisms, developing novel approaches to enhance patient care.

At Oncovask Therapeutics, we specialize in understanding and overcoming cancer therapy resistance. With advanced research and innovative solutions, we're dedicated to improving treatment outcomes for patients facing this challenge. Our focus drives us to push boundaries, offering hope and personalized care strategies in the fight against cancer.

CRISPR-Cas9 based therapy

Utilizing CRISPR-Cas9 technology, our therapy targets specific genetic sequences, offering precise and potentially curative treatments for a range of diseases.

At Oncovask Therapeutics, we excel in utilizing CRISPR-Cas9 technology for precise therapeutic interventions. Our focus is on pioneering personalized treatments that target diseases with unprecedented accuracy, revolutionizing the landscape of healthcare.

COMMENTS FROM EXPERTS

Our EXPERT TEAM

BIOTECHNOLOGY
90%

Oncovask Therapeutics has a medical testing laboratory service that offers a complete range of tests for diagnosis, screening or evaluation.

VACCINES
80%

Oncovask Therapeutics has a medical testing laboratory service that offers a complete range of tests for cancer diagnosis, screening or evaluation.

MEDICAL RESEARCH
70%

Oncovask Therapeutics has a medical testing laboratory service that offers a complete range of tests for diagnosis, screening or evaluation.

Meet Our Best Expert